13th Jan 2016 09:53
LONDON (Alliance News) - Immunology and oncology-focused biotechnology firm Tiziana Life Sciences PLC on Wednesday said it has raised GBP709,406 through the issue of convertible loan notes.
The company has issued 472,938 notes to existing investors, convertible at any time after the end of 2016 at 150.00 pence per share. Shares in Tiziana were untraded on Wednesday, having last traded at 194.00p.
The funds will be used to back the development of Tiziana's key clinical stage assets, to cover its licence agreement liabilities and for working capital.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
TILS.L